COMMUNIQUÉS West-GlobeNewswire

-
AIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023 Financial Results on April 2, 2024, and Host Conference Call and Webcast
26/03/2024 -
Save the date for ALK’s Capital Markets Day on 4 June 2024
26/03/2024 -
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients
26/03/2024 -
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
26/03/2024 -
American Shared Hospital Services Pays Tribute to Ernest A. Bates, M.D., Founder and Former Chairman and CEO
26/03/2024 -
Forbes Recognizes Luna as a Top-Rated Employer in its List of America’s Best Employers for 2024
26/03/2024 -
Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3L
26/03/2024 -
PharmAla Biotech Signs Sale Agreement with Numinus
26/03/2024 -
Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024
26/03/2024 -
Dyadic Announces Publication of C1 Monoclonal Antibody in Nonhuman Primate Study in Nature Communications
26/03/2024 -
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
26/03/2024 -
Entera Bio Announces Key Regulatory Milestone for Oral PTH(1-34) Peptide (EB613) Phase 3 Program: FDA Ruling on Qualifying BMD as a Surrogate Endpoint for Osteoporosis Drugs is Expected Within 10 Months
26/03/2024 -
Shockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare Conference
26/03/2024 -
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Fourth Quarter 2023 Financial Results on April 1, 2024
26/03/2024 -
Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines
26/03/2024 -
Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC
26/03/2024 -
Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada
26/03/2024 -
Surgery Partners, Inc. Announces New Senior Notes Offering
26/03/2024 -
Essential Pharma and AcedrA Biopharmaceuticals sign Distribution Agreement to commercialize essential medicines in the Middle East and North Africa region
26/03/2024
Pages